Allianz is closing in on the psychologically significant €400 mark, buoyed by an unusual convergence of forces that has investors rethinking the German insurer’s potential. At €396.60, the stock sits just €0.70 below its fresh 52-week high of €397.30, having gained 4.64% in the past seven days and nearly 16% over twelve months. The near-term catalyst is a tentative peace agreement between the US and Iran, which promises to reopen the Strait of Hormuz, lowering oil prices and easing geopolitical risk — a tailwind that disproportionately lifts global heavyweights like Allianz.
Alongside this macro shift, a potentially transformative acquisition is taking shape. Allianz has emerged as the preferred bidder for HSBC Life Singapore, with talks entering their final phase and a price tag of up to $2 billion on the table. The deal would plug a strategic gap in Allianz’s Asian footprint and aligns with management’s push for profitable expansion rather than cost-cutting. Both Allianz and HSBC have declined to comment, but the market has already priced in the optimism: the stock closed at €393.90 on Monday before extending gains the following day.
Meanwhile, Berenberg has issued a radical re-rating of the entire European insurance sector. The bank raised its price target for Allianz from €504 to €684, arguing that a sector price-to-earnings ratio of roughly 12 is unjustified and that a multiple of 20 is more appropriate. Should that re-rating materialise, €400 would be merely a waypoint. The bank’s conviction is reinforced by Allianz’s robust operational foundation: a Solvency II ratio of 221% and first-quarter 2026 operating profit of €4.5 billion provide ample cover for both organic growth and deal-making.
Should investors sell immediately? Or is it worth buying Allianz?
Behind the scenes, a hefty share buyback programme is also supporting the stock. The management has already repurchased over €1 billion worth of shares by early June, with the intention to cancel them — a clear signal of confidence in the company’s intrinsic value. On the charts, the picture remains clean. The relative strength index stands at 65.2, indicating strong momentum without overheating, and volatility is a modest 21% for a DAX heavyweight. The 200-day moving average at €371.45 is comfortably below the current price, confirming the long-term uptrend.
Short-term profit-taking around the €400 round number would be normal, but the fundamental setup is as compelling as it has been in years. Allianz is no longer just a reliable dividend payer; it is a blue chip caught between geopolitical détente, a bold Asia push, and a sector-wide re-rating that, if Berenberg is right, has only just begun.
Ad
Allianz Stock: Buy or Sell?! New Allianz Analysis from June 16 delivers the answer:
The latest Allianz figures speak for themselves: Urgent action needed for Allianz investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 16.
Allianz: Buy or sell? Read more here...
